Kidul 20 Tablet contains Duloxetine 20 mg, a selective serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain. Duloxetine acts by increasing the levels of serotonin and norepinephrine in the central nervous system, which helps to restore the balance of neurotransmitters and alleviate symptoms associated with depression and anxiety. Additionally, its analgesic properties provide relief from neuropathic and chronic pain conditions. Kidul 20 Tablet is administered orally, typically once daily, with or without food, as prescribed by a healthcare professional. It is essential to adhere to the prescribed dosage and duration of therapy to achieve optimal therapeutic outcomes and minimize the risk of adverse effects. Common side effects may include nausea, dry mouth, dizziness, fatigue, and constipation, which are generally transient and mild. Patients should be monitored for any signs of worsening depression, suicidal ideation, or unusual behavioral changes, especially during the initial treatment period. Caution is advised in patients with hepatic or renal impairment, and the drug should be used under strict medical supervision in individuals with a history of bipolar disorder or seizures. Kidul 20 Tablet should not be abruptly discontinued to avoid withdrawal symptoms.